PREVENTIVE MEDICINE and HEALTH PROMOTION Immunizations

Case Logo


Preventive Medicine & Health Promotion: Fourth Year Elective
Faculty Contact List    |     CWRU School of Medicine    |   Campus Map    |    CWRU Vistors Guide     
   
   

 

 

<< | 10 | 11 | 12 | 13 | 14 | 15 |

Next Page Button


PREVENTION

References

    1. Preventive Medicine and Health Promotion at the CWRU School of Medicine: A review of the Published Curriculum of the First Three Years  David Litaker, MD MSc

    2. Healthy People 2010 – Health Status  http://www.healthypeople.gov/document/html/uih/uih_2.htm#status

    3. Canadian Guide to Clinical Preventive Health – Preventive Guidelines:  Their Role in Clinical Prevention and Health Promotion  http://www.hc-sc.gc.ca/hppb/healthcare/pubs/clinical_preventive/pdf/guide.pdf

    4. Canadian Guide to Clinical Preventive Health – Methodology  http://www.hc-sc.gc.ca/hppb/healthcare/pubs/clinical_preventive/pdf/methe.pdf

    5. Guide to Clinical Preventive Services  http://odphp.osophs.dhhs.gov/pubs/guidecps/PDF/Frontmtr.PDF

    6. Guide to Clinical Preventive Health – Improving the Delivery of Clinical Preventive Services

    7. Managing Hypertension:  The Current Clinical Strategies.  Norman M. Kaplan, M.D.  Hypertension Disease Management Guide, 2000 Second Edition

    8. Unpublished data for 1999-2000 computed by M. Wolz, National Heart, Lung, and Blood Institute; JNC 6, referenced by The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7 Express)

    9. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7 Express)

    10. Reference Card from the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)

    11. Primary Prevention of Hypertension. Clinical and Public Health Advisory from the National High Blood Pressure Education Program.  Whelton PK, Jiang H, Lawrence JA et al. JAMA 2002;288:1882-8

    12. Centers for Disease Control and Prevention (CDC) www.cdc.gov

    13. Vasan RS, Beiser A, Seshadri S, et al.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002;287:   1003-10.

    14. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)

    15. Douglas JG & Onwuzulike KC, 2002 ‘Pathophysiology of Essential (Primary) Hypertension’ in Hypertension Secrets pp26,7 eds. DE Hricik, JT Wright &, MC Smith, Hanley & Belfus Inc., Philadelphia

    16. Primary Prevention of Hypertension: Clinical  and Public Health Advisory from the National High Blood Pressure Education Program

    17. Stamler J, Stamler R, Neaton JD.  Blood pressure, systolic and diastolic, and cardiovascular risks. U.S. population data. Arch Intern Med. 1993;153(5):598 – 615

    18. Flack JM, Neaton J, Grimm R, et al. For the Multiple Risk Factor Intervention Trial Research Group.  Blood pressure mortality among men with prior myocardial infarction.  Circulation. 1995;92(9):2437-45.

    19. Whelton PK, Epidemiology of hypertension.  Lancet. 1994; 344(8915):101-6.

    20. He J, Whelton PK. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.  J Hypertens. 1999;17(Suppl 2):S7-S13.

    21. Stamler J, Stamler R, Neaton JD, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young and middle-aged men and women.  JAMA. 1999;282(21):2012-8

    22. Appel LJ, Statson WB. Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med 1993;349:454-457 in The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)

    23. An Economic Evaluation of the JNC Hypertension Guidelines Using Data from a Randomized Controlled Trial   J Am Board Fam Pract 12(2):105-114, 1999. © 1999 American Board of Family Practice

    24. Healthy People 2010.  US Department of Health and Human Services, November 2000

    25. Data from 1988 -1994 – age adjusted to year 2000 standard

    26. Data from 1988 – age adjusted to year 2000 standard population

    27. Hypertension Online reference: Coresh J, et al. Arch Intern Med. 2001;161(9):1207-1216.

    28. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7 Express). Table 2 from unpublished data for 1999-2000 computed by M. Wolz, National Heart, Lung, and Blood Institute; JNC 6.

    29. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) figure 1

    30. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) figure 2

    31. JNC VI The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) Risk Stratification

    32. Lifestyle modification and Blood Pressure Control.  Thomas G. Pickering, MD, Phil (Reprinted) JAMA , April 23/30, 2003 – Vol 289, No. 16: 2131-2

    33. Primary Prevention of Hypertension. Clinical and Public Health advisory from the National High Blood Pressure Education Program. Whelton PK, Jiang H, Lawrence JA et al.

    34. National High Blood Pressure Education Program Working Group.  National High Blood Pressure Education Program working group report on hypertension in diabetes.  Hypertension 1994;23:145-58 in The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)

    35. Korchen TA. Attenuation of hypertension by insulin-sensitizing agents.  Hypertension 1996;28:219-223 in The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)

    36. Vasan RS, Larson MG, Leip EP, et al.  Assessment of frequency of progression to hypertension in nonhypertensive participants in the Framingham Heart Study: A cohort study.  Lancet  2002;358:1682-2 in The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7 Express).

      

    Previous Page Button
    << | 10 | 11 | 12 | 13 | 14 | 15 |

    Next Page Button

    TOP OF PAGE